Buy Lorlatinib, enjoy exclusive benefits and get the latest information immediately!

Lorlatinib is a highly selective tyrosine kinase (ALK) inhibitor and belongs to a new generation of targeted drugs in the treatment of non-small cell lung cancer (NSCLC). The drug has shown excellent efficacy in the treatment of ALKpositive NSCLC patients, especially in first-line treatment.

Lorlatinib is unique in that it is highly selective for multipleALK mutations. The ALK fusion gene is a mutation in NSCLC that causes abnormal proliferation of cancer cells. Lorlatinib blocks this abnormal signaling pathway by inhibiting the activity of the ALK fusion protein, thereby inhibiting the growth of cancer cells.

In addition, lorlatinib also shows certain inhibitory effects on related proteins such as ROS1, IGF-1R and InsR, expanding its breadth of therapeutic scope. This makes lorlatinib not only outstanding in first-line treatment, but also has stronger advantages in combating multiple resistance mechanisms.

In clinical trials, lorlatinib has shown encouraging efficacy. The CROWN study, a clinical trial of lorlatinib in first-line treatment, confirmed that lorlatinib significantly prolonged patients' progression-free survival (PFS) compared with traditional treatments (such as crizotinib). This result provides solid evidence for the superiority of lorlatinib in improving patient survival and quality of life.

Patients need to pay close attention to their doctor's advice and treatment plan while using lorlatinib. The dosage and frequency of use of the drug will be determined according to the patient's specific situation, and the doctor will make individual adjustments. In addition, because lorlatinib may cause some side effects, such as visual impairment, abnormal liver function, etc., patients need to receive regular medical monitoring during treatment.

Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. Please consult the local hospital pharmacy for specific medical insurance reimbursement prices. There are original lorlatinib drugs and cheaper generic drugs abroad. The cheaper ones are the original drug from Turkey, which costs more than 1,000 yuan, and the original drug from Hong Kong, China, which costs about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.